# Vascular resistance

﻿
Vascular resistance

Vascular resistance is a term used to define the resistance to flow that must be overcome to push blood through the circulatory system. The resistance offered by the peripheral circulation is known as the systemic vascular resistance (SVR), while the resistance offered by the vasculature of the lungs is known as the pulmonary vascular resistance (PVR). The systemic vascular resistance may also be referred to as the total peripheral resistance. Vasoconstriction (i.e., decrease in blood vessel diameter) increases SVR, whereas vasodilation (increase in diameter) decreases SVR.

Units for measuring vascular resistance are dyn·s·cm-5 or pascal seconds per cubic metre (Pa·s/m³). Pediatric cardiologists use hybrid reference units (HRU), also known as Wood units, as they were introduced by Dr. Paul Wood. To convert from Wood units to MPa·s/m3 you must multiply by 8, or to dyn·s·cm-5 you must multiply by 80.

Calculation of resistance

The basic tenet of calculating resistance is that flow is equal to driving pressure divided by resistance.

The pulmonary vascular resistance can therefore be calculated in units of dyn·s·cm-5 as

:$frac \left\{80 cdot \left(mean pulmonary arterial pressure - pulmonary capillary wedge pressure\right)\right\} \left\{cardiac output\right\}$

where the pressures are measured in units of millimetres of mercury (mmHg) and the cardiac output is measured in units of litres per minute (L/min).

Determinants of vascular resistance

The major determinant of vascular resistance is "small arteriolar" (known as resistance arterioles) tone. These vessels are from 450 µm down to 100 µm in diameter. (As a comparison, the diameter of a capillary is about 3 to 4 µm.)

Another determinant of vascular resistance is the "pre-capillary arterioles". These arterioles are less than 100 µm in diameter. They are sometimes known as autoregulatory vessels.

Regulation of vascular resistance

There are many factors that alter the vascular resistance. Many of the platelet-derived substances, including serotonin, are vasodilatory when the endothelium is intact and are vasoconstrictive when the endothelium is damaged.

Cholinergic stimulation causes release of endothelium-derived relaxing factor (EDRF) (later it was discovered that EDRF was nitric oxide) from intact endothelium, causing vasodilatation. If the endothelium is damaged, cholinergic stimulation causes vasoconstriction.

Adenosine probably doesn't play a role in maintaining the vascular resistance in the resting state. However, it causes vasodilatation and decreased vascular resistance during hypoxia. Adenosine is formed in the myocardial cells during hypoxia, ischemia, or vigorous work, due to the breakdown of high-energy phosphate compounds (e.g., adenosine monophosphate, AMP). Most of the adenosine that is produced leaves the cell and acts as a direct vasodilator on the vascular wall. "Because adenosine acts as a direct vasodilator, it is not dependent on an intact endothelium to cause vasodilatation."

Adenosine causes vasodilatation in the small and medium sized resistance arterioles (less than 100 µm in diameter). When adenosine is administered it can cause a coronary steal phenomenon, where the vessels in healthy tissue dilate as much as the ischemic tissue and more blood is shunted away from the ischemic tissue that needs it most. This is the principle behind adenosine stress testing.

Adenosine is quickly broken down by adenosine deaminase, which is present in red cells and the vessel wall.

Coronary vascular resistance

The regulation of tone in the coronary arteries is a complex subject. There are a number of mechanisms for regulating coronary vascular tone, including metabolic demands (ie: hypoxia), neurologic control, and endothelial factors (ie: EDRF, endothelin).

Local metabolic control (based on metabolic demand) is the most important mechanism of control of coronary flow. Decreased tissue oxygen content and increased tissue CO2 content act as vasodilators Acidosis acts as a direct coronary vasodilator and also potentiates the actions of adenosine on the coronary vasculature.

References

1. Grossman W, Baim D. "Grossman's" "Cardiac Catheterization, Angiography,and Intervention", Sixth Edition. Page 172, Tabe 8.1 ISBN 0-683-30741-X

ee also

*Cardiac output

Wikimedia Foundation. 2010.

### Look at other dictionaries:

• vascular resistance — n resistance to blood flow through blood vessels and esp. arterioles <internal vessel diameter is inversely proportional to pulmonary and systemic vascular resistance> see peripheral vascular resistance * * * the opposition to blood flow in …   Medical dictionary

• peripheral vascular resistance — n vascular resistance to the flow of blood in peripheral arterial vessels that is typically a function of the internal vessel diameter, vessel length, and blood viscosity called also peripheral resistance * * * total peripheral r …   Medical dictionary

• peripheral vascular resistance index — a measure of the total vascular resistance, normalized for body surface area …   Medical dictionary

• pulmonary vascular resistance — the vascular resistance of the pulmonary circulation, equal to the difference between the mean pulmonary arterial pressure and the left atrial filling pressure divided by the cardiac output …   Medical dictionary

• Resistance — may refer to: Physics * Electrical resistance, a measure of the degree to which an object opposes an electric current through it * Friction, the force that opposes (relative) motion ** Drag (physics) ( air resistance ), fluid or gas forces… …   Wikipedia

• Resistance — Opposition to something, or the ability to withstand it. For example, some forms of staphylococcus are resistant to treatment with antibiotics. * * * 1. A force exerted in opposition to an active force. 2. The opposition in a conductor to the… …   Medical dictionary

• Vascular endothelial growth factor — (VEGF) a sub family of growth factors, more specifically of platelet derived growth factor family of cystine knot growth factors. They are important signaling proteins involved in both vasculogenesis (the de novo formation of the embryonic… …   Wikipedia

• Vascular endothelial growth factor C — is a VEGF. The human gene encoding it is VEGFC. PBB Summary section title = summary text = The protein encoded by this gene is a member of the platelet derived growth factor/vascular endothelial growth factor (PDGF/VEGF) family, is active in… …   Wikipedia

• Resistance, vascular — The opposition to the flow of blood across a vascular bed …   Medical dictionary

• Total peripheral resistance — (TPR) is the sum of the resistance of all peripheral vasculature in the systemic circulation. This should not be confused with Pulmonary Vascular Resistance, which is the resistance in the pulmonary vasculature.MeasurementTPR is represented… …   Wikipedia